Xenon Pharmaceuticals Inc (XENE) — Cash Flow Reinvestment Rate
Xenon Pharmaceuticals Inc (XENE) has a Cash Flow Reinvestment Rate of 3.05x as of December 2019, reinvesting $60.27 Million (capex $595.00K plus investments $-59.67 Million) from operating cash flow of $19.73 Million. Explore Xenon Pharmaceuticals Inc capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Xenon Pharmaceuticals Inc Cash Flow Reinvestment Rate (2012–2014)
Historical reinvestment intensity for Xenon Pharmaceuticals Inc across 2 annual periods. Also explore Xenon Pharmaceuticals Inc asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Xenon Pharmaceuticals Inc (2012–2014)
Year-by-year capital reinvestment analysis for Xenon Pharmaceuticals Inc. For live market cap and broader valuation context, see XENE stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2014 | 12.20x | $3.24 Million | $266.00K | $1.53 Million | ▲ +105562.5% |
| 2012 | 0.01x | $526.00K | $45.57 Million | $526.00K | — |